vs
MEDALLION FINANCIAL CORP（MFIN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是MEDALLION FINANCIAL CORP的1.1倍（$75.5M vs $70.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 25.4%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 15.0%）
Mahindra & Mahindra金融服务有限公司（MMFSL）是一家印度农村非银行金融公司，总部位于孟买。该公司是印度头部拖拉机融资机构之一，在印度全国拥有超过一千家分支机构
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MFIN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$70.6M
营收增速更快
PBYI
高出2.3%
25.4%
两年增速更快
PBYI
近两年复合增速
15.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $70.6M | $75.5M |
| 净利润 | $12.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 29.3% | 22.7% |
| 净利率 | 17.3% | — |
| 营收同比 | 25.4% | 27.7% |
| 净利润同比 | 20.3% | — |
| 每股收益（稀释后） | $0.50 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MFINPBYI
| Q4 25 | $70.6M | $75.5M | ||
| Q3 25 | $58.7M | $54.5M | ||
| Q2 25 | $62.6M | $52.4M | ||
| Q1 25 | $63.0M | $46.0M | ||
| Q4 24 | $56.3M | $59.1M | ||
| Q3 24 | $53.3M | $80.5M | ||
| Q2 24 | $51.0M | $47.1M | ||
| Q1 24 | $53.3M | $43.8M |
净利润MFINPBYI
| Q4 25 | $12.2M | — | ||
| Q3 25 | $7.8M | $8.8M | ||
| Q2 25 | $11.1M | $5.9M | ||
| Q1 25 | $12.0M | $3.0M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $8.6M | $20.3M | ||
| Q2 24 | $7.1M | $-4.5M | ||
| Q1 24 | $10.0M | $-4.8M |
毛利率MFINPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率MFINPBYI
| Q4 25 | 29.3% | 22.7% | ||
| Q3 25 | 33.2% | 17.6% | ||
| Q2 25 | 31.1% | 12.7% | ||
| Q1 25 | 32.1% | 8.7% | ||
| Q4 24 | 32.8% | 22.6% | ||
| Q3 24 | 26.6% | 27.4% | ||
| Q2 24 | 24.3% | -4.6% | ||
| Q1 24 | 33.6% | -5.3% |
净利率MFINPBYI
| Q4 25 | 17.3% | — | ||
| Q3 25 | 13.2% | 16.2% | ||
| Q2 25 | 17.7% | 11.2% | ||
| Q1 25 | 19.1% | 6.5% | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 16.1% | 25.2% | ||
| Q2 24 | 13.9% | -9.6% | ||
| Q1 24 | 18.8% | -11.0% |
每股收益（稀释后）MFINPBYI
| Q4 25 | $0.50 | $0.26 | ||
| Q3 25 | $0.32 | $0.17 | ||
| Q2 25 | $0.46 | $0.12 | ||
| Q1 25 | $0.50 | $0.06 | ||
| Q4 24 | $0.43 | $0.40 | ||
| Q3 24 | $0.37 | $0.41 | ||
| Q2 24 | $0.30 | $-0.09 | ||
| Q1 24 | $0.42 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $136.3M | $97.5M |
| 总债务越低越好 | $216.0M | $22.7M |
| 股东权益账面价值 | $408.6M | $130.3M |
| 总资产 | $3.0B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.53× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MFINPBYI
| Q4 25 | $136.3M | $97.5M | ||
| Q3 25 | $72.5M | $94.4M | ||
| Q2 25 | $110.4M | $96.0M | ||
| Q1 25 | $131.5M | $93.2M | ||
| Q4 24 | $98.2M | $101.0M | ||
| Q3 24 | $120.6M | $96.7M | ||
| Q2 24 | $87.7M | $96.8M | ||
| Q1 24 | $54.8M | $107.2M |
总债务MFINPBYI
| Q4 25 | $216.0M | $22.7M | ||
| Q3 25 | $215.7M | $34.0M | ||
| Q2 25 | $199.9M | $45.3M | ||
| Q1 25 | $199.7M | $56.7M | ||
| Q4 24 | $232.2M | $68.0M | ||
| Q3 24 | $232.0M | $79.3M | ||
| Q2 24 | $230.8M | $90.7M | ||
| Q1 24 | $225.6M | $102.0M |
股东权益MFINPBYI
| Q4 25 | $408.6M | $130.3M | ||
| Q3 25 | $397.4M | $115.3M | ||
| Q2 25 | $389.9M | $104.7M | ||
| Q1 25 | $380.2M | $97.1M | ||
| Q4 24 | $370.2M | $92.1M | ||
| Q3 24 | $362.4M | $71.1M | ||
| Q2 24 | $354.0M | $48.5M | ||
| Q1 24 | $349.0M | $51.0M |
总资产MFINPBYI
| Q4 25 | $3.0B | $216.3M | ||
| Q3 25 | $2.9B | $202.9M | ||
| Q2 25 | $2.9B | $194.9M | ||
| Q1 25 | $2.8B | $196.2M | ||
| Q4 24 | $2.9B | $213.3M | ||
| Q3 24 | $2.9B | $220.7M | ||
| Q2 24 | $2.8B | $205.0M | ||
| Q1 24 | $2.6B | $214.1M |
负债/权益比MFINPBYI
| Q4 25 | 0.53× | 0.17× | ||
| Q3 25 | 0.54× | 0.30× | ||
| Q2 25 | 0.51× | 0.43× | ||
| Q1 25 | 0.53× | 0.58× | ||
| Q4 24 | 0.63× | 0.74× | ||
| Q3 24 | 0.64× | 1.12× | ||
| Q2 24 | 0.65× | 1.87× | ||
| Q1 24 | 0.65× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 10.35× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流MFINPBYI
| Q4 25 | $126.3M | $14.4M | ||
| Q3 25 | $67.0M | $9.7M | ||
| Q2 25 | $-10.7M | $14.1M | ||
| Q1 25 | $36.3M | $3.6M | ||
| Q4 24 | $108.7M | $15.6M | ||
| Q3 24 | $24.6M | $11.0M | ||
| Q2 24 | $27.6M | $1.0M | ||
| Q1 24 | $32.3M | $11.2M |
自由现金流MFINPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率MFINPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度MFINPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率MFINPBYI
| Q4 25 | 10.35× | — | ||
| Q3 25 | 8.63× | 1.10× | ||
| Q2 25 | -0.97× | 2.41× | ||
| Q1 25 | 3.02× | 1.21× | ||
| Q4 24 | 10.72× | — | ||
| Q3 24 | 2.86× | 0.54× | ||
| Q2 24 | 3.89× | — | ||
| Q1 24 | 3.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
